By Charlie Loran • 23 October 2020 • 8:30
THE coronavirus vaccine being developed by Oxford University and AstraZeneca “works perfectly” and builds strong immunity, a study has said.
The team at the university are thought to be the frontrunners in the race to produce a safe vaccine.
In early trials, it has been shown to safely trigger an immune response in volunteers.
Usually, vaccines use a weakened virus or small amounts of it, but the innovative Oxford jab causes the body to make part of the virus itself.
Researchers led by the University of Bristol have now found this new technique works for the coronavirus.
The study used cells in the lab and found the vaccine delivers instructions for the Covid protein, which cells then copy thousands of times to produce it in large amounts.’
Dr David Matthews, from Bristol’s School of Cellular and Molecular Medicine (CMM), who led the research, said, “Until now, the technology hasn’t been able to provide answers with such clarity, but we now know the vaccine is doing everything we expected and that is only good news in our fight against the illness.”
Sarah Gilbert, who leads the Oxford University vaccine trial, said, “The study confirms that large amounts of the coronavirus spike protein are produced with great accuracy, and this goes a long way to explaining the success of the vaccine in inducing a strong immune response.”
Share this story
Subscribe to our Euro Weekly News alerts to get the latest stories into your inbox!
By signing up, you will create a Euro Weekly News account if you donâ€™t already have one. Review our
Manchester born mummy with a two year old diva (2020), living on the Costa del Sol for just short of a decade.
Former chef and restaurateur, holistic health fanatic and lover of long words.
Share your story with us by emailing [email protected], by calling +34 951 38 61 61 or by messaging our Facebook page www.facebook.com/EuroWeeklyNews
Download our media pack in either English or Spanish.